HCA Healthcare, Inc. $HCA Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,562 shares of the company’s stock after purchasing an additional 4,824 shares during the period. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $25,117,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of HCA. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the first quarter worth about $26,000. Saudi Central Bank acquired a new stake in HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC acquired a new stake in HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.5%

Shares of NYSE:HCA opened at $446.58 on Monday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $461.56. The firm has a market capitalization of $104.50 billion, a P/E ratio of 17.26, a PEG ratio of 1.41 and a beta of 1.40. The firm’s 50 day moving average is $414.84 and its two-hundred day moving average is $382.33.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HCA shares. KeyCorp upped their price objective on HCA Healthcare from $370.00 to $465.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Mizuho increased their target price on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Robert W. Baird increased their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Saturday. Finally, Barclays increased their price target on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $437.19.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.